CN Patent
CN108003149A — 一种卡格列净晶型i及其制备方法
Assigned to Chongqing Pharmaceutical Research Institute Co Ltd · Expires 2018-05-08 · 8y expired
What this patent protects
本发明公开了一种卡格列净晶型Ⅰ,该晶型的X‑射线粉末衍射图谱在2θ值为4.4±0.2°、8.4±0.2°、16.8±0.2°、17.5±0.2°、18.0±0.2°、22.8±0.2°的位置有特征衍射峰。该晶型理化性质稳定,适合其各种制剂的制造。
USPTO Abstract
本发明公开了一种卡格列净晶型Ⅰ,该晶型的X‑射线粉末衍射图谱在2θ值为4.4±0.2°、8.4±0.2°、16.8±0.2°、17.5±0.2°、18.0±0.2°、22.8±0.2°的位置有特征衍射峰。该晶型理化性质稳定,适合其各种制剂的制造。
Drugs covered by this patent
- Invokana (CANAGLIFLOZIN) · Johnson & Johnson
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.